OMERACT 10 Sharp Symposium: Important Findings in Examination of Imaging Methods for Measurement of Joint Damage in Rheumatoid Arthritis

Vibeke Strand*, Sarah R. Kingsbury, Thasia G. Woodworth, Robert Landewe, Mikkel Ostergaard, Charles Peterfy, Desiree van der Heijde, Maria-Antonietta D'Agostino, Walter P. Maksymowych, Paul P Tak, George Wells, Philip G. Conaghan

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Web of Science)

Abstract

The Sharp Symposium was held at the Outcome Measures in Rheumatology Clinical Trials 2010 meeting (OMERACT 10) in honor of the late John Sharp, consummate rheumatologist and researcher. The symposium focused on the status of current scoring methods in radiography, magnetic resonance imaging (MRI), and ultrasound (US) in rheumatoid arthritis (RA), as well as on the use of soluble and tissue biomarkers in RA, with the aim of updating recommendations regarding methods for enhanced detection, monitoring, and prediction of joint damage in clinical trials. (J Rheumatol 201138:2009-13; doi:10.3899/jrheum.110415)
Original languageEnglish
Pages (from-to)2009-2013
JournalJournal of Rheumatology
Volume38
Issue number9
DOIs
Publication statusPublished - Sep 2011

Keywords

  • OMERACT
  • ULTRASOUND
  • RADIOGRAPHS
  • MAGNETIC RESONANCE IMAGING
  • BIOMARKERS

Cite this